Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
Osterman, Mark T, Gordon, Ilyssa O, Davis, Elisabeth M, Ciorba, Matthew, Glover, Sarah C, Abraham, Bincy, Khan, Freeha, Guo, Xueyan, Yee, Eric U, Allard, Felicia D, Claggett, Brian, Shen, Bo, Liu, JulLanguage:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1093/ibd/izz222
Date:
September, 2019
File:
PDF, 670 KB
english, 2019